BR100 Decreased By (-0.29%)
BR30 Decreased By (-0.02%)
KSE100 Decreased By (-0.2%)
KSE30 Decreased By (-0.29%)
AGHA 7.70 Increased By ▲ 0.01 (0.13%)
BECO 5.35 Increased By ▲ 0.04 (0.75%)
BML 60.71 Decreased By ▼ -0.52 (-0.85%)
BOP 36.06 Increased By ▲ 0.06 (0.17%)
CNERGY 11.50 Increased By ▲ 0.25 (2.22%)
CSIL 6.22 Increased By ▲ 0.05 (0.81%)
FCCL 56.99 Increased By ▲ 0.11 (0.19%)
FFL 16.52 Increased By ▲ 0.01 (0.06%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.35 Decreased By ▼ -0.07 (-0.94%)
KOSM 6.10 Increased By ▲ 0.05 (0.83%)
LOTCHEM 27.18 Decreased By ▼ -0.02 (-0.07%)
MLCF 102.30 Decreased By ▼ -0.79 (-0.77%)
NBP 206.25 Decreased By ▼ -1.38 (-0.66%)
NCPL 64.70 Increased By ▲ 2.78 (4.49%)
NPL 74.40 Increased By ▲ 2.22 (3.08%)
OGDC 318.40 Decreased By ▼ -0.09 (-0.03%)
PACE 11.18 Increased By ▲ 0.12 (1.08%)
PAEL 44.64 Increased By ▲ 0.26 (0.59%)
PIBTL 16.89 Decreased By ▼ -0.01 (-0.06%)
PPL 221.00 Decreased By ▼ -1.48 (-0.67%)
PRL 64.10 Increased By ▲ 0.29 (0.45%)
PTC 73.69 Increased By ▲ 0.53 (0.72%)
SSGC 27.18 Decreased By ▼ -0.07 (-0.26%)
TBL 9.90 Increased By ▲ 0.02 (0.2%)
TELE 8.75 Decreased By ▼ -0.06 (-0.68%)
TPL 20.37 Increased By ▲ 0.03 (0.15%)
TPLP 15.00 Increased By ▲ 0.03 (0.2%)
TREET 23.90 Decreased By ▼ -0.20 (-0.83%)
TRG 62.40 Increased By ▲ 0.03 (0.05%)

Widely used blood tests to detect tuberculosis are "dangerous" to patients because they are unreliable and can produce wrong results, the World Health Organisation warned Sunday. The UN health agency said it will issue an unprecedented recommendation against using such tests for the infectious lung disease that affects some 14 million people world-wide.
As much as a third of the world's population is thought to harbour the bacteria that causes TB. "The tests are not reliable and a waste of money and time, putting prorer care at risk," said Mario Raviglione, the director of WHO's Stop TB department.
A review of the tests has shown that they produce too many false negative and false positive, according to WHO.
Raviglione told The Associated Press that the blood tests "are in fact dangerous to patients, since some cases will not be detected and some will be called TB when in fact they do not have it,"
The WHO guidance will be issued later this week. It is the first time that WHO has issued a "negative" policy, specifically counselling against the use of a particular method for diagnosing a disease.
The use of TB blood tests is particularly common in developing countries such as India, where an estimated 3 million people are infected with the disease.
The Lancet medical journal reported in January that some of the blood testing kits used there are made in developed countries where such tests aren't licensed. They are ordered by doctors who receive greater commissions for the blood tests than for the older and more reliable sputum microscopy method, the journal reported.

Copyright Associated Press, 2010

Comments

Comments are closed for this article.